157 related articles for article (PubMed ID: 3626433)
21. Sequential evaluation of alpha-2b-interferon treatment in 128 patients with hairy cell leukemia.
Golomb HM; Fefer A; Golde DW; Ozer H; Portlock C; Silber R; Rappeport J; Ratain MJ; Thompson J; Bonnem EM
Semin Oncol; 1987 Jun; 14(2 Suppl 2):13-7. PubMed ID: 3589701
[TBL] [Abstract][Full Text] [Related]
22. Human recombinant interferon-alpha-2 in the treatment of patients with hairy cell leukemia.
Skotnicki AB; Wolska-Smolen T; Blicharski J; Zduńczyk A; Sasiadek U; Pituch-Noworolska A
Cancer Detect Prev; 1988; 12(1-6):511-22. PubMed ID: 3180143
[TBL] [Abstract][Full Text] [Related]
23. Treatment with low dose human recombinant interferon-alpha-2-ARG induces complete remission in patients with hairy cell leukemia.
Gastl G; Denz H; Abbrederis C; Huber H; Troppmair J; Wiegele J; Niederwieser D; Flener R; Huber C
Onkologie; 1985 Jun; 8(3):143-4. PubMed ID: 3895095
[TBL] [Abstract][Full Text] [Related]
24. Splenectomy following complete response to alpha interferon (IFN) therapy in patients with hairy cell leukemia (HCL): results of the HCL88 protocol. Italian Cooperative Group for the Study of Hairy Cell Leukemia (ICGHCL).
Damasio EE; Frassoldati A
Leuk Lymphoma; 1994; 14 Suppl 1():95-8. PubMed ID: 7820061
[TBL] [Abstract][Full Text] [Related]
25. Natural IFN-alpha therapy in hairy-cell leukaemia (namalva-type IFN--Wellferon).
Worman CP; Nethersell AB; Bottomley JM; Apostolov K; Barker W; Cawley JC
Klin Wochenschr; 1987 Jul; 65(14):685-7. PubMed ID: 3306138
[TBL] [Abstract][Full Text] [Related]
26. Randomized study of the duration of treatment with interferon alfa-2B in patients with hairy cell leukemia.
Golomb HM; Ratain MJ; Fefer A; Thompson J; Golde DW; Ozer H; Portlock C; Silber R; Rappeport J; Bonnem E
J Natl Cancer Inst; 1988 May; 80(5):369-73. PubMed ID: 3282078
[TBL] [Abstract][Full Text] [Related]
27. Treatment of hairy cell leukemia with increasing doses of recombinant alpha A interferon.
Holmes R; Schwarz MA; Whiteside MG; Firkin FC
Aust N Z J Med; 1988 Jun; 18(4):557-62. PubMed ID: 3196242
[TBL] [Abstract][Full Text] [Related]
28. Comparison of clinical efficacy and toxicity of conventional and optimum biological response modifying doses of interferon alpha-2C in the treatment of hairy cell leukemia: a retrospective analysis of 39 patients.
Gastl G; Werter M; De Pauw B; Nerl C; Aulitzky W; von Lüttichau I; Tilg H; Thaler J; Lang A; Abbrederis K
Leukemia; 1989 Jun; 3(6):453-60. PubMed ID: 2725061
[TBL] [Abstract][Full Text] [Related]
29. 2'-Deoxycoformycin (Pentostatin) in hairy cell leukemia: response in patients refractory to interferon alpha.
Ho AD; Kuse R; Prümmer O; Porzsolt F; Hunstein W
Klin Wochenschr; 1987 Oct; 65(20):975-9. PubMed ID: 3501501
[TBL] [Abstract][Full Text] [Related]
30. Hairy cell leukemia: an interferon deficient disease?
Hofmann V; Fehr J; Sauter C; Ottino J
Cancer Treat Rev; 1985 Dec; 12 Suppl B():33-7. PubMed ID: 3833328
[TBL] [Abstract][Full Text] [Related]
31. Treatment of hairy cell leukaemia with recombinant alpha-interferon.
Bezwoda WR; Hesdorffer CS; Dansey RD; Lewis D
S Afr Med J; 1987 Nov; 72(10):661-2. PubMed ID: 3686262
[TBL] [Abstract][Full Text] [Related]
32. The alpha 2 (r) interferon in the treatment of hairy cell leukemia: progressive report of 25 cases.
Mandelli F; Cafolla A; Annino L; Amadori S; Gentile A; Bianco P; Dianzani F
J Biol Regul Homeost Agents; 1987; 1(4):177-82. PubMed ID: 3332545
[TBL] [Abstract][Full Text] [Related]
33. [The dose of alpha interferon in induction and maintainance therapy of hairy cell leukemia].
Kloke O; May D; Wandl U; Niederle N
Onkologie; 1988; 11 Suppl 2():41-5. PubMed ID: 3065687
[TBL] [Abstract][Full Text] [Related]
34. Hairy cell leukemia: bone marrow changes following splenectomy and alpha-interferon therapy.
Pangalis GA; Kittas C; Viniou N; Kokkinou S; Variamis H; Paizis P; Melanthiou F; Fessas P
Leukemia; 1987 Apr; 1(4):343-6. PubMed ID: 3669761
[TBL] [Abstract][Full Text] [Related]
35. Interferon is effective in hairy-cell leukaemia.
Worman CP; Catovsky D; Bevan PC; Camba L; Joyner M; Green PJ; Williams HJ; Bottomley JM; Gordon-Smith EC; Cawley JC
Br J Haematol; 1985 Aug; 60(4):759-63. PubMed ID: 3875366
[TBL] [Abstract][Full Text] [Related]
36. Mid-term observations on the efficacy of alpha-interferon in hairy cell leukemia and status of the interferon system of patients in remission.
Quesada JR; Lepe-Zuniga JL; Gutterman JU
Leukemia; 1987 Apr; 1(4):317-9. PubMed ID: 3669753
[TBL] [Abstract][Full Text] [Related]
37. Whole blood assay for NK activity in splenectomized and non-splenectomized hairy cell leukemia patients during IFN-alpha-2b treatment.
Nielsen B; Hokland P; Ellegaard J; Hasselbalch H; Hokland M
Leuk Res; 1989; 13(6):451-6. PubMed ID: 2770329
[TBL] [Abstract][Full Text] [Related]
38. Treatment of hairy-cell leukemia with recombinant alpha 2-interferon.
Berneman ZN; Gastl G; Gangji D; van Camp B; Jochmans K; Aulitzky W; Flament J; Peetermans ME; Huber C
Eur J Cancer Clin Oncol; 1986 Aug; 22(8):987-90. PubMed ID: 3770055
[TBL] [Abstract][Full Text] [Related]
39. Interferon in the treatment of hairy cell leukemia.
Thompson JA; Fefer A
Cancer; 1987 Feb; 59(3 Suppl):605-9. PubMed ID: 3542183
[TBL] [Abstract][Full Text] [Related]
40. Splenectomy after initial therapy with alpha-IFN in patients with hairy-cell leukemia (HCL): a multi-center study by the Italian Cooperative Group for HCL. Preliminary results.
Damasio EE; Federico M; Frassoldati A; Lamparelli T; Annino L; Bernasconi C; Chisesi T; Foá R; Lauria F; Pagnucco G
Eur J Haematol Suppl; 1990; 52():29-31. PubMed ID: 2279542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]